PTEN/MMAC1/TEP1 Suppresses the Tumorigenicity and Induces G1 Cell Cycle Arrest in Human Glioblastoma Cells

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1998 Dec 23

PMID 9860981

Citations 135

Authors

D M Li

H Sun

Affiliations

Soon will be listed here.

Abstract

PTEN/MMAC1/TEP1 is a tumor suppressor that possesses intrinsic phosphatase activity. Deletions or mutations of its encoding gene are associated with a variety of human cancers. However, very little is known about the molecular mechanisms by which this important tumor suppressor regulates cell growth. Here, we show that PTEN expression potently suppressed the growth and tumorigenicity of human glioblastoma U87MG cells. The growth suppression activity of PTEN was mediated by its ability to block cell cycle progression in the G1 phase. Such an arrest correlated with a significant increase of the cell cycle kinase inhibitor p27(KIP1) and a concomitant decrease in the activities of the G1 cyclin-dependent kinases. PTEN expression also led to the inhibition of Akt/protein kinase B, a serine-threonine kinase activated by the phosphatidylinositol 3-kinase (PI 3-kinase) signaling pathway. In addition, the effect of PTEN on p27(KIP1) and the cell cycle can be mimicked by treatment of U87MG cells with LY294002, a selective inhibitor of PI 3-kinase. Taken together, our studies suggest that the PTEN tumor suppressor modulates G1 cell cycle progression through negatively regulating the PI 3-kinase/Akt signaling pathway, and one critical target of this signaling process is the cyclin-dependent kinase inhibitor p27(KIP1).

Citing Articles

FBXO32-mediated degradation of PTEN promotes lung adenocarcinoma progression.

Wu J, Wen T, Marzio A, Song D, Chen S, Yang C Cell Death Dis. 2024; 15(4):282.

PMID: 38643215 PMC: 11032391. DOI: 10.1038/s41419-024-06635-4.

Synthetic lethal approaches to target cancers with loss of PTEN function.

Ertay A, Ewing R, Wang Y Genes Dis. 2023; 10(6):2511-2527.

PMID: 37533462 PMC: 7614861. DOI: 10.1016/j.gendis.2022.12.015.

Cell Reprogramming for Regeneration and Repair of the Nervous System.

Clark I, Roman A, Fellows E, Radha S, Var S, Roushdy Z Biomedicines. 2022; 10(10).

PMID: 36289861 PMC: 9599606. DOI: 10.3390/biomedicines10102598.

PTEN Dual Lipid- and Protein-Phosphatase Function in Tumor Progression.

Liu A, Zhu Y, Chen W, Merlino G, Yu Y Cancers (Basel). 2022; 14(15).

PMID: 35954330 PMC: 9367293. DOI: 10.3390/cancers14153666.

Trifluoperazine and Its Analog Suppressed the Tumorigenicity of Non-Small Cell Lung Cancer Cell; Applicability of Antipsychotic Drugs to Lung Cancer Treatment.

Jeong J, Park H, Yoo H, Kim E, Jeon B, Lee J Biomedicines. 2022; 10(5).

PMID: 35625784 PMC: 9138877. DOI: 10.3390/biomedicines10051046.

References

Pear W, Scott M, Nolan G . Generation of high-titer, helper-free retroviruses by transient transfection. Methods Mol Med. 2014; 7:41-57. DOI: 10.1385/0-89603-484-4:41. View

Steck P, Ligon A, Cheong P, Yung W, Pershouse M . Two tumor suppressive loci on chromosome 10 involved in human glioblastomas. Genes Chromosomes Cancer. 1995; 12(4):255-61. DOI: 10.1002/gcc.2870120404. View

Zhang H, Kobayashi R, Galaktionov K, Beach D . p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell. 1995; 82(6):915-25. DOI: 10.1016/0092-8674(95)90271-6. View

Hunter T, Pines J . Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell. 1994; 79(4):573-82. DOI: 10.1016/0092-8674(94)90543-6. View

Roche S, Koegl M, Courtneidge S . The phosphatidylinositol 3-kinase alpha is required for DNA synthesis induced by some, but not all, growth factors. Proc Natl Acad Sci U S A. 1994; 91(19):9185-9. PMC: 44772. DOI: 10.1073/pnas.91.19.9185. View

Pershouse M, STUBBLEFIELD E, Hadi A, Killary A, Yung W, Steck P . Analysis of the functional role of chromosome 10 loss in human glioblastomas. Cancer Res. 1993; 53(20):5043-50. View

Kato J, Matsushime H, Hiebert S, Ewen M, Sherr C . Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 1993; 7(3):331-42. DOI: 10.1101/gad.7.3.331. View

Deimling A, Louis D, Wiestler O . Molecular pathways in the formation of gliomas. Glia. 1995; 15(3):328-38. DOI: 10.1002/glia.440150312. View

Serrano M, Lin A, McCurrach M, Beach D, Lowe S . Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997; 88(5):593-602. DOI: 10.1016/s0092-8674(00)81902-9. View

10.

Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang S . PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997; 275(5308):1943-7. DOI: 10.1126/science.275.5308.1943. View

11.

Steck P, Pershouse M, Jasser S, Yung W, Lin H, Ligon A . Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 1997; 15(4):356-62. DOI: 10.1038/ng0497-356. View

12.

Li D, Sun H . TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res. 1997; 57(11):2124-9. View

13.

Toker A, Cantley L . Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature. 1997; 387(6634):673-6. DOI: 10.1038/42648. View

14.

Myers M, Stolarov J, Eng C, Li J, Wang S, Wigler M . P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci U S A. 1997; 94(17):9052-7. PMC: 23024. DOI: 10.1073/pnas.94.17.9052. View

15.

Takuwa N, Takuwa Y . Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts. Mol Cell Biol. 1997; 17(9):5348-58. PMC: 232385. DOI: 10.1128/MCB.17.9.5348. View

16.

Furnari F, Lin H, Huang H, Cavenee W . Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc Natl Acad Sci U S A. 1997; 94(23):12479-84. PMC: 25009. DOI: 10.1073/pnas.94.23.12479. View

17.

Eng C . Genetics of Cowden syndrome: through the looking glass of oncology. Int J Oncol. 1998; 12(3):701-10. DOI: 10.3892/ijo.12.3.701. View

18.

Bacqueville D, Casagrande F, Perret B, Chap H, Darbon J, Breton-Douillon M . Phosphatidylinositol 3-kinase inhibitors block aortic smooth muscle cell proliferation in mid-late G1 phase: effect on cyclin-dependent kinase 2 and the inhibitory protein p27KIP1. Biochem Biophys Res Commun. 1998; 244(3):630-6. DOI: 10.1006/bbrc.1997.7885. View

19.

Downward J . Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol. 1998; 10(2):262-7. DOI: 10.1016/s0955-0674(98)80149-x. View

20.

Maehama T, Dixon J . The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 1998; 273(22):13375-8. DOI: 10.1074/jbc.273.22.13375. View